Observational study on primary liver cancer in South China
Factors Influencing the Occurrence and Long-term Survival of Patients With Primary Liver Cancer: A Cohort Study in South China
This study looks at what affects how often people in South China get primary liver cancer and how long they live after being diagnosed.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4000 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Sun Yat-sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT03297255 on ClinicalTrials.gov |
What this trial studies
This longitudinal observational cohort study aims to investigate the factors influencing the occurrence and long-term survival of patients diagnosed with primary liver cancer. It collects detailed clinical information, including AJCC/TNM stage, MELD score, Child-Pugh score, and BCLC stage, from professional doctors. Patients will be followed up every two years after therapy to assess clinical outcomes such as death, recurrence, and metastasis.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18-80 years who have recently been diagnosed with primary liver cancer and have not yet received any treatment.
Not a fit: Patients who have multiple primary tumors or refuse to participate in the study may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the factors affecting survival and recurrence in primary liver cancer patients, potentially leading to improved management strategies.
How similar studies have performed: While observational studies on cancer prognosis are common, this specific cohort study focuses on primary liver cancer in South China, which may provide novel insights into this particular population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age 18-80 years * consistent with primary liver cancer diagnostic criteria * first diagnosis (from diagnosis to admission interval of less than a month) * did not do any treatment of liver cancer Exclusion Criteria: * refused to participate in this study * suffering from more than two kinds of primary tumors
Where this trial is running
Guangzhou, Guangdong
- Sun Yat-sen University Cancer Center — Guangzhou, Guangdong, China (Recruiting)
Study contacts
- Study coordinator: Zhu Huilian, Professor
- Email: zhuhl@mail.sysu.edu.cn
- Phone: +86 20 87331811
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.